Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Myovant Sciences Ltd. | 181,972 | reported | 10 Mar 2023 | tx 9+379,372−490,483 |
| 4D Molecular Therapeutics, Inc. | 130,000 | reported | 06 Mar 2025 | tx 3+434,634 |
| BridgeBio Oncology Therapeutics, Inc. | 22,806 | reported | 01 Apr 2026 | tx 4+761,900−524 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 01 Apr 2026 | TAX_WITHHOLDING | BridgeBio Oncology Therapeutics, Inc. | 524 | 9.03 USD | |
| 10 Mar 2026 | GRANT_AWARD | BridgeBio Oncology Therapeutics, Inc. | 23,330 | 0.00 USD | |
| 10 Mar 2026 | GRANT_AWARD | BridgeBio Oncology Therapeutics, Inc. | 105,000 | 0.00 USD | deriv |
| 26 Aug 2025 | GRANT_AWARD | BridgeBio Oncology Therapeutics, Inc. | 633,570 | 0.00 USD | deriv |
| 06 Mar 2025 | GRANT_AWARD | 4D Molecular Therapeutics, Inc. | 130,000 | 0.00 USD | deriv |
| 11 Dec 2023 | GRANT_AWARD | 4D Molecular Therapeutics, Inc. | 75,000 | 0.00 USD | deriv |
| 01 Oct 2023 | GRANT_AWARD | 4D Molecular Therapeutics, Inc. | 229,634 | 0.00 USD | deriv |
| 10 Mar 2023 | OTHER | Myovant Sciences Ltd. | 20,724 | — | |
| 10 Mar 2023 | OTHER | Myovant Sciences Ltd. | 181,972 | — | |
| 10 Mar 2023 | OTHER | Myovant Sciences Ltd. | 165,192 | — | deriv |
| 10 Mar 2023 | OTHER | Myovant Sciences Ltd. | 111,111 | — | deriv |
| 16 Dec 2022 | SALE | Myovant Sciences Ltd. | 2,241 | 26.75 USD | |
| 16 Sept 2022 | SALE | Myovant Sciences Ltd. | 9,243 | 18.86 USD | |
| 15 Apr 2022 | GRANT_AWARD | Myovant Sciences Ltd. | 111,111 | 0.00 USD | |
| 15 Sept 2021 | GRANT_AWARD | Myovant Sciences Ltd. | 103,069 | 0.00 USD | |
| 15 Sept 2021 | GRANT_AWARD | Myovant Sciences Ltd. | 165,192 | 0.00 USD | deriv |